Thematic Issue: Immuno-Oncology and Immunotherapy

---

A. A. Zamyatnin, Jr.^1,2,a

¹Sechenov First Moscow State Medical University, Institute of Molecular Medicine, 119991 Moscow, Russia

²Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992 Moscow, Russia

Received April 17, 2019; Revised April 17, 2019; Accepted April 18, 2019

---

Currently, the use of immunotherapeutic approaches for creating new efficient therapeutic agents for cancer treatment is considered as one of the most promising areas in oncology. Despite significant advances in immuno-oncology during the recent years, some unresolved problems remain. The articles included in this thematic issue highlight the topical aspects of cancer immunotherapy by presenting different viewpoints of scientists, physicians, and drug developers.

---

KEY WORDS: immunotherapy, immuno-oncology, anticancer vaccines, tumor-associated macrophages

DOI: 10.1134/S0006297919070010

---